BeOne Medicines AG Announced Q1 2026 Earnings on May 6, 2026, Reporting "Product revenue reached $1.5 billion in the quarter"
BeOne Medicines AG announced Q1 2026 earnings, reporting $1.5 billion in product revenue and $1.1 billion for BRUKINSA. The company achieved an 89% gross margin and provided full-year revenue guidance of $6.3 billion to $6.5 billion.